DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,943 INR | -0.28% |
|
-2.33% | +2.50% |
| Apr. 19 | Dr. Reddy's Labortories Launches Care Plan for IBS Patients | MT |
| Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Business Summary
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Number of employees: 25,863
Sales per Business
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Global Generics
86.9
%
| 179,170 | 83.6 % | 213,768 | 86.9 % | +19.31% |
Pharmaceutical Services and Active Ingredients
11.8
%
| 30,740 | 14.3 % | 29,069 | 11.8 % | -5.44% |
Others
1.2
%
| 2,870 | 1.3 % | 3,042 | 1.2 % | +5.99% |
Sales per region
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
43.4
%
| 80,564 | 37.6 % | 106,683 | 43.4 % | +32.42% |
Others
27.4
%
| 68,962 | 32.2 % | 67,469 | 27.4 % | -2.16% |
India
20.5
%
| 43,986 | 20.5 % | 50,499 | 20.5 % | +14.81% |
Russia
8.6
%
| 20,879 | 9.7 % | 21,228 | 8.6 % | +1.67% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
| Chairman | 56 | 93-01-17 | |
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-31 |
K. Randhir Singh
CMP | Compliance Officer | - | 22-03-16 |
Archana Bhaskar
IRO | Public Communications Contact | 57 | 17-05-31 |
Amith Agarwal
IRC | Investor Relations Contact | - | - |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 21-04-30 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
| Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 07-06-04 |
Shikha Sharma
BRD | Director/Board Member | 64 | 19-01-30 |
Claudio Albrecht
BRD | Director/Board Member | - | 23-05-09 |
Arun M. Kumar
BRD | Director/Board Member | 72 | 22-07-31 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | Dec. 28 |
| Director/Board Member | 64 | 22-01-06 | |
Alpna Seth
BRD | Director/Board Member | 60 | 23-09-18 |
Penny Wan
BRD | Director/Board Member | - | 22-01-27 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 166,874,039 | 152,709,398 ( 91.51 %) | 345,564 ( 0.2071 %) | 91.51 % |
Company contact information
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.com
Group companies
| Name | Category and Sector |
|---|---|
Aurigene Discovery Technologies Ltd.
 Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Dr. Reddy's Laboratories SA
 Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Pharmaceutical Services Ltd.
 Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.50% | 11.87B | |
| +24.60% | 654B | |
| +24.08% | 552B | |
| -5.63% | 356B | |
| +15.37% | 319B | |
| +7.38% | 295B | |
| +3.26% | 211B | |
| +0.78% | 206B | |
| -9.69% | 147B | |
| -6.63% | 144B |
- Stock Market
- Equities
- DRREDDY Stock
- Company Dr. Reddy's Laboratories Limited
